• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非离子表面活性剂囊泡,即脂质体,作为抗利什曼原虫药物葡萄糖酸锑钠的递送系统。

Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate.

作者信息

Baillie A J, Coombs G H, Dolan T F, Laurie J

出版信息

J Pharm Pharmacol. 1986 Jul;38(7):502-5. doi: 10.1111/j.2042-7158.1986.tb04623.x.

DOI:10.1111/j.2042-7158.1986.tb04623.x
PMID:2875149
Abstract

Liver and serum concentrations of antimony in the mouse have been determined after administration of sodium stibogluconate in the free, liposomal and niosomal form. High liver and low serum values were attained by the use of both vesicular formulations. Niosomal sodium stibogluconate was shown to be more active than free drug against experimental murine visceral leishmaniasis, an effect apparently dependent on maintaining high drug levels in the infected reticuloendothelial system.

摘要

在以游离、脂质体和非离子型表面活性剂泡囊形式给予葡糖酸锑钠后,测定了小鼠肝脏和血清中的锑浓度。使用这两种囊泡制剂均能使肝脏中的锑浓度升高,血清中的锑浓度降低。结果表明,非离子型表面活性剂泡囊包裹的葡糖酸锑钠在抗实验性小鼠内脏利什曼病方面比游离药物更具活性,这一效果显然取决于在受感染的网状内皮系统中维持较高的药物水平。

相似文献

1
Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate.非离子表面活性剂囊泡,即脂质体,作为抗利什曼原虫药物葡萄糖酸锑钠的递送系统。
J Pharm Pharmacol. 1986 Jul;38(7):502-5. doi: 10.1111/j.2042-7158.1986.tb04623.x.
2
Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis.用于在实验性小鼠内脏利什曼病中递送葡萄糖酸锑钠的囊泡系统(非离子表面活性剂泡囊和脂质体)
J Pharm Pharmacol. 1988 Mar;40(3):161-5. doi: 10.1111/j.2042-7158.1988.tb05210.x.
3
Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate.可生物降解微球:聚丙基淀粉微粒作为抗利什曼原虫药物葡萄糖酸锑钠的递送系统
J Pharm Pharmacol. 1987 Oct;39(10):832-5. doi: 10.1111/j.2042-7158.1987.tb05126.x.
4
Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice.
J Pharm Pharmacol. 1989 Feb;41(2):87-91. doi: 10.1111/j.2042-7158.1989.tb06399.x.
5
Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate.BALB/c小鼠的内脏利什曼病:游离葡糖酸锑钠给药后的锑组织分布及寄生虫抑制情况
Ann Trop Med Parasitol. 1992 Feb;86(1):35-40. doi: 10.1080/00034983.1992.11812628.
6
Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.泡囊型和游离型葡萄糖酸锑钠制剂对杜氏利什曼原虫临床分离株的疗效。
Antimicrob Agents Chemother. 2001 Dec;45(12):3555-9. doi: 10.1128/AAC.45.12.3555-3559.2001.
7
Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations.用游离和囊泡型葡萄糖酸锑钠制剂治疗后,杜氏利什曼原虫感染的BALB/c小鼠的免疫反应
Int J Immunopharmacol. 1997 Apr;19(4):195-203. doi: 10.1016/s0192-0561(97)00009-x.
8
Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles.
FEBS Lett. 1989 Mar 13;245(1-2):204-8. doi: 10.1016/0014-5793(89)80222-4.
9
The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent.葡萄糖酸锑钠对感染杜氏利什曼原虫的BALB/c小鼠的治疗效果具有器官依赖性。
J Pharm Pharmacol. 1988 May;40(5):370-3. doi: 10.1111/j.2042-7158.1988.tb05271.x.
10
Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.十六烷基磷酸胆碱(米替福新)、两性霉素B脂质体和葡萄糖酸锑钠(喷他脒)对免疫缺陷型重度联合免疫缺陷(scid)小鼠体内杜氏利什曼原虫的活性。
Antimicrob Agents Chemother. 2001 Jun;45(6):1872-5. doi: 10.1128/AAC.45.6.1872-1875.2001.

引用本文的文献

1
Development, physicochemical characterization, and antimicrobial evaluation of niosome-loaded oregano essential oil against fish-borne pathogens.载有牛至精油的非离子表面活性剂囊泡对鱼源性病原体的研制、理化特性及抗菌评价
Heliyon. 2024 Feb 19;10(5):e26486. doi: 10.1016/j.heliyon.2024.e26486. eCollection 2024 Mar 15.
2
The Evolution of Emerging Nanovesicle Technologies for Enhanced Delivery of Molecules into and across the Skin.用于增强分子透皮递送的新兴纳米囊泡技术的发展
Pharmaceutics. 2024 Feb 13;16(2):267. doi: 10.3390/pharmaceutics16020267.
3
Niosomes: a novel targeted drug delivery system for cancer.
尼欧索米:一种新型癌症靶向药物传递系统。
Med Oncol. 2022 Sep 29;39(12):240. doi: 10.1007/s12032-022-01836-3.
4
An Overview of Nanotechnologies for Drug Delivery to the Brain.用于脑部药物递送的纳米技术概述。
Pharmaceutics. 2022 Jan 19;14(2):224. doi: 10.3390/pharmaceutics14020224.
5
Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.用于眼部疾病的脂质体药物递送系统——最新进展与未来前景
Nanomaterials (Basel). 2020 Jun 18;10(6):1191. doi: 10.3390/nano10061191.
6
Niosomes of active phytochemicals: antidiabetic, antineuropathic, anti-inflammatory, and possible mechanisms of action.活性植物化学物质的脂质体:抗糖尿病、抗神经病变、抗炎及可能的作用机制
Chin Med. 2020 May 1;15:40. doi: 10.1186/s13020-020-00321-1. eCollection 2020.
7
Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier.脂质体:一种通过血脑屏障进行天然药物递送的有前景的纳米载体。
Adv Pharmacol Sci. 2018 Dec 11;2018:6847971. doi: 10.1155/2018/6847971. eCollection 2018.
8
Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell.载纳米变形脂质体的葡萄糖酸锑钠用于治疗利什曼病的局部治疗:巨噬细胞作为靶细胞。
Drug Deliv. 2018 Nov;25(1):1595-1606. doi: 10.1080/10717544.2018.1494222.
9
Nanostructured delivery systems with improved leishmanicidal activity: a critical review.具有增强杀利什曼原虫活性的纳米结构递送系统:一项批判性综述。
Int J Nanomedicine. 2017 Jul 26;12:5289-5311. doi: 10.2147/IJN.S140363. eCollection 2017.
10
Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives.眼部给药中的非离子表面活性剂囊泡:创新方法与前景
Biomed Res Int. 2014;2014:263604. doi: 10.1155/2014/263604. Epub 2014 Jun 3.